CC
ABBV icon

Corsicana & Co’s AbbVie ABBV Stock Holding History

Corsicana & Co’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.98M Buy
11,827
+425
+4% +$91.4K 1.44% 21
2026
Q1 		$2.39M Buy
11,402
+35
+0.3% +$7.76K 1.51% 21
2025
Q4 		$2.6M Sell
11,367
-110
-1% -$25.1K 1.46% 21
2025
Q3 		$2.66M Buy
+11,477
New +$2.34M 1.49% 20
2022
Q3 		$1.72M Buy
12,785
+415
+3% +$59.6K 1.45% 20
2022
Q2 		$1.9M Buy
12,370
+442
+4% +$67.5K 1.5% 18
2022
Q1 		$1.93M Buy
11,928
+555
+5% +$80.6K 1.25% 23
2021
Q4 		$1.54M Buy
11,373
+185
+2% +$21.9K 0.93% 30
2021
Q3 		$1.21M Buy
11,188
+9,325
+501% +$1.07M 0.77% 38
2021
Q2 		$210K Buy
+1,863
New +$210K 0.13% 71

Other funds holding ABBV

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Corsicana & Co's ABBV Position: Q2 2026 in Review

Corsicana & Co increased its AbbVie (ABBV) stake by 3.7% in Q2 2026, buying an estimated $91.4K and bringing the position to 11,827 shares worth $2.98M. The position accounts for 1.44% of the portfolio, ranked #21.

Corsicana & Co first reported a position in ABBV in Q2 2021 and has held it in 10 quarters since. 2,313 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Corsicana & Co held 11,827 shares of AbbVie worth $2.98M as of Q2 2026.
  • Corsicana & Co bought 425 AbbVie shares in Q2 2026, an estimated $91.4K.
  • AbbVie made up 1.44% of Corsicana & Co's portfolio in Q2 2026, its #21 holding.
  • Corsicana & Co first reported a position in AbbVie in Q2 2021 and has held it in 10 quarters since.
  • 2,313 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Corsicana & Co's 13F filing for Q2 2026, filed 24 Jul 2026.